Virtu Financial LLC Altamira Therapeutics Ltd. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.27 - $120.04 $30,207 - $13.4 Million
111,880 Added 866.82%
124,787 $36,000
Q2 2022

Aug 09, 2022
BUY
$0.48 - $1.66 $6,195 - $21,425
12,907 New
12,907 $6,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email